348. The Anti-platelet Aggregatory Substance in Human Placenta

スポンサーリンク

概要

著者

関連論文

Immunohistochemical Localization of PGI (Placental Coagulation Inhibitor)
Anticoagulant Mechanism of Placental Circulation : Placental Coagulation Inhibitor(PCI) and Thrombomodulin
348. The Anti-platelet Aggregatory Substance in Human Placenta
67. Prolactin Secretion in Polycystic Ovary Syndrome
Relationship between Fetal Heart Rate Accelerations and the Duration of Fetal Breathing at Twenty-five to Thiry-two Weeks of Gestation
89. Gap Junction Formation between the Smooth Muscle Cells of Nonpregnant and Term Pregnant Human Myomertrium and Uterine Cervix
396. Significance of Early Pregnancy Factor (EPF) in Reproductive Immunology and its Clnical Application
325. Urinary Kallikrein Levels during Normal Pregnancy Puerperium, Hypertensive Pregnancy and Puerperal Hypertension
290. Kinin Forming Enzyme System in Obstetrics
386. Fundamental and Clinical Investigations of Microbubble Stability Method (Pattle et al; 1979) which has Application to the Diagnosis of Fetal Lung Maturity
268. Immunological Studies of the Apoprotein of Surfactant Isolated from Amniotic Fluid
325. The Effect of Terbutaline on the Maturation of Fetal Rabbit Lung
277. Behavior of Fibrinolytic Enzyme System during Pregnancy
279. Rapid Methods of Measuring Kinin Forming, Coagulation and Fibrinolytic Enzyme Systems by Chromogenic Tripeptide Substrates in Obstetrics
Changes of Plasma-α_2-Plasmin Inhibitor Complex during Normal Pregnancy and Toxemia of Pregnancy
74. Preovulatory Changes in Plasma Prekallikrein
227. Assessment of Fetal Well-Being with the Combination Method : Fetal Breathing Movement (FBM) and the Non-Stress Test (NST)
111. The Difference of Prothrombin (PT) Activity of Cord Blood Plasma in NATTO-Diet Pregnant and Non-NATTO-Diet Pregnant
289. Heparin Therapy in DIC

もっと見る

スポンサーリンク